EQT completes sale of shares in Galderma Group AG

Core Insights - EQT completed the placement of 20 million shares in Galderma Group AG, generating aggregate gross proceeds of approximately CHF 2.6 billion [1][4] - EQT received gross proceeds of around CHF 690 million from this placement [2] Financial Details - The placement was finalized on October 30, 2025, through an accelerated bookbuilding process [1][2] - The joint global coordinators and bookrunners for the placement included Citigroup Global Markets, Goldman Sachs International, Jefferies, Merrill Lynch International, Morgan Stanley, and UBS [2]